Rep. Katko’s COVID PREPARE Act Receives Backing from Bipartisan Problem Solvers Caucus

August 4, 2020
Press Release

Katko: With COVID-19 Cases Continuing to Spike Across the Country, Bipartisan Bill Ensures the Administration & Federal Government are Fully Prepared to Combat a Resurgence in COVID-19

SYRACUSE, NY— U.S. Rep. John Katko (NY-24) today announced the Problem Solvers Caucus has officially endorsed the COVID Preparedness, Response, and Effective Planning for Advanced Requirements by the Executive Branch (PREPARE) Act, bipartisan legislation he introduced last month alongside U.S. Rep. Brad Schneider (D, IL-10).

The Problem Solvers Caucus is a bipartisan group in Congress, equally divided between Democrats and Republicans, who are committed to forging bipartisan cooperation on key issues. Rep. Katko’s bill received the caucus’s endorsement after more than 75 percent of the 50-member caucus agreed to support the bill.

“I’m honored the Problem Solvers Caucus has endorsed my bipartisan bill, the COVID Preparedness, Response, and Effective Planning for Advanced Requirements by the Executive Branch (PREPARE) Act,” said Rep. Katko. “With Central New York and communities across the nation still reeling from the devastating impacts of the pandemic, it’s extremely troubling to now see reports of COVID-19 spiking in many states. Americans deserve assurances that the Administration and Federal Government are fully prepared to prevent and respond to additional waves of the virus. This legislation will require federal agencies to develop and submit reports to Congress on how they would mitigate and respond to a resurgence of COVID-19.”

With COVID-19 cases continuing to spike across the country, Rep. Katko’s COVID PREPARE Act ensures the Administration and Federal Government are fully prepared to respond to this crisis, and future COVID-19 resurgences. Specifically, the legislation requires federal agencies to develop and submit to Congress comprehensive plans detailing how they would respond to a potential resurgence of COVID-19, including measurable goals, anticipated challenges, and how they will consult with Congress.

 

###